CAI vs NUE · rev $812.0M vs P/E 25, rev $19.89B
Caris Life Sciences, Inc. Common Stock (CAI) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
CAI currently screens at market cap $5.22B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the CAI and NUE stock pages for the full models.
Not investment advice.